Allogene Therapeutics, Inc. Common Stock (ALLO) is a publicly traded Healthcare sector company. As of August 7, 2026, ALLO trades at $1.97 with a market cap of $673.05M and a P/E ratio of -2.24. ALLO moved +1.03% today. Year to date, ALLO is +45.93%; over the trailing twelve months it is +85.85%. Its 52-week range spans $0.86 to $4.46. Analyst consensus is strong buy with an average price target of $10.00. Rallies surfaces ALLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ALLO, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.97 |
| Market Cap | $673.05M |
| P/E Ratio | -2.24 |
| EPS | $-0.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.46 |
| 52-Week Low | $0.86 |
| Volume | 2.90M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-190.89M |
| Gross Margin | 0.00% |
6 analysts cover ALLO: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.00.